
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
JCR Pharmaceuticals has signed a licence agreement with Alexion, AstraZeneca Rare Disease, for its proprietary JUST-AAV capsids to advance genomic medicines. The JUST-AAV platform features a range of vector types optimised for several target tissues, …